Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN)

In today's trading, Nervgen Pharma Corp shares closed at $2.84 after opening the day at $2.50. It traded at a low of $2.47 to a high of $2.90.

Share prices boosted 13.60% from the previous day's close of $2.50.

Today across North America, the TSX Composite closed 0.02% at 21793.90, the S&P 500 closed 0.39% at 5469.30, the Dow Jones Industrial Average closed -0.76% at 39112.16 and the Nasdaq Composite closed 1.26% at 17717.65.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 117,936 shares was traded during the session, with total trades of 245, with an average volume of 82,293 in the last five days.

Trading across the entire TSX-V saw 2,436 price advancers against 2,777 declines and 109 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 77.50%, while in 2024, they have advanced 5.19%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $174.82 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..